The two cytolytic T lymphocyte (CTL) receptors centrally involved in antigen-specific recognition and triggering of responses are the T cell receptor (TCR), which binds antigen, and CD8, which binds conserved determinants on class I proteins. Our previous work has demonstrated that artificial membranes bearing ligands for only these two receptors are ffective in stimulating responses by murine allogeneic CTL and by H-2 restricted, peptidespecific CTL. Using cloned CTL specific for peptides, we have defined some of the parameters which influence formation of the antigenic peptide-class I complex. These studies have demonstrated a critical role for b2-microglobulin in complex formation. Guided by these results from assays of functional recognition, we have obtained preliminary evidence for binding of radiolabeled peptides to purified class I proteins. Proposed studies will define the biochemical parameters for peptide binding to class I and correlate these with functional recognition by CTL. We have also recently obtained evidence that CD8 is 'activated' via the TCR. Only following 'activation' can CD8-class I dependent adhesion of CTL be detected. Furthermore, CD8 binding to class I results in delivery of a transmembrane signal needed to activate at least some CTL responses. Proposed studies will focus on developing a better understanding of the class I structural requirements for effective interaction with 'activated' CD8, and on determining the relative quantitative contributions of TCR and CD8 interactions to antigen binding and activation of CTL responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI031524-02
Application #
3146536
Study Section
Allergy and Immunology Study Section (ALY)
Project Start
1991-07-01
Project End
1993-02-28
Budget Start
1992-06-01
Budget End
1993-02-28
Support Year
2
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Medical Biology Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Goldberg, Jodi; Shrikant, Protul; Mescher, Matthew F (2003) In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen). J Immunol 170:228-35
Jensen, P L; Mescher, M F (2001) Role of phosphoinositide 3-kinase in TCR-signaled regulation of CD8-mediated adhesion to class I MHC protein. Eur J Immunol 31:3612-21
Tham, E L; Jensen, P L; Mescher, M F (2001) Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins. J Immunol Methods 249:111-9
Ni, H T; Deeths, M J; Mescher, M F (2001) LFA-1-mediated costimulation of CD8+ T cell proliferation requires phosphatidylinositol 3-kinase activity. J Immunol 166:6523-9
Shrikant, P; Mescher, M F (1999) Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness. J Immunol 162:2858-66
Kedl, R M; Mescher, M F (1998) Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response. J Immunol 161:674-83
Deeths, M J; Mescher, M F (1997) B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells. Eur J Immunol 27:598-608
Ybarrondo, B; O'Rourke, A M; McCarthy, J B et al. (1997) Cytotoxic T-lymphocyte interaction with fibronectin and vitronectin: activated adhesion and cosignalling. Immunology 91:186-92
Mescher, M F; Savelieva, E (1997) Stimulation of tumor-specific immunity using tumor cell plasma membrane antigen. Methods 12:155-64
Mescher, M F; Rogers, J D (1996) Immunotherapy of established murine tumors with large multivalent immunogen and cyclophosphamide. J Immunother Emphasis Tumor Immunol 19:102-12

Showing the most recent 10 out of 14 publications